Detecting and Treating Subclinical Anthracycline Therapy Related Cardiac Dysfunction in Low Income Country.
Status:
Unknown status
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The objective of this research is to describe the burden of subclinical anthracycline therapy
related cardiac dysfunction( ATRCD) by applying international guideline on Uganda cancer
patient and to evaluate the significance of treating subclinical ATRCD with carvedilol.